I’m glad that you are so certain about the timeline of developments that may be relevant to investors. Thanks for reposting to share your keen foresight with us 😶
In fact, collaborations, partnerships, or even a buyout could conceivably be initiated at any time. Logically, the further along a product is in clinical development, the greater its prospective value and the stronger the company’s bargaining position—especially if clinical data and peer-reviewed analyses continue to accumulate in support of combo efficacy, in addition to the safety and efficacy data gathered through the ongoing MHRA-supported UK Specials Program.
Market Data 
Markets 
AI
